跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,744 条关于
“ENV-308”
全部
8,744
临床试验
6,030
药物
2,055
机构
88
资讯
571
9个月前
Enveda Receives FDA Clearance for First-in-Class Oral Obesity Therapy ENV-308, Doses First Patient in Phase 1 Trial
去年
Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials
去年
ENV-101 Shows Promising Results in Idiopathic Pulmonary Fibrosis Treatment, Reducing Pulmonary Vessel Volume
5个月前
Enveda's ENV-294 Shows 85% EASI Reduction in Phase 1b Atopic Dermatitis Trial
去年
Enveda's AI-Discovered Anti-Inflammatory ENV-294 Clears Phase 1 Safety Trial, Advances to Atopic Dermatitis Study
9个月前
Enveda Advances First-in-Class Oral Therapy ENV-294 to Phase 2 Trials for Atopic Dermatitis and Asthma
去年
GeNeuro's GNK-301 Shows Promise in Precision Medicine Approach for ALS
2个月前
Kairos Pharma Reports Zero Grade 3+ Toxicities in Phase 1 Trial of ENV-105 for EGFR-Mutated Lung Cancer
去年
Enveda's AI-Driven Natural Product Candidate ENV-294 Enters Phase I for Atopic Dermatitis
去年
First-in-Human HIV Vaccine Induces Virus-Specific Neutralizing Antibodies
第 1 页,共 58 页
上一页
下一页